OncoDxRx is a startup focusing only on one-of-a-kind liquid biopsy technologies, leveraging on our exclusive knowhow and technology barrier.

We are a patient-centered innovation-driven company. There are total eight one-of-a-kind transformational technologies in our pipelines covering cancer early detection, treatment selection, DNA repair activity measurement, recurrence to therapeutics. We welcome technology transfer, licensing or partnership to further our vision and mission. Our flagship PGA platforms which are CLIA/CAP validated and are ready for commercialization. PGA is the world-first technology to bridge gene to drug, conne...

We are a patient-centered innovation-driven company. There are total eight one-of-a-kind transformational technologies in our pipelines covering cancer early detection, treatment selection, DNA repair activity measurement, recurrence to therapeutics. We welcome technology transfer, licensing or partnership to further our vision and mission. Our flagship PGA platforms which are CLIA/CAP validated and are ready for commercialization. PGA is the world-first technology to bridge gene to drug, connecting patient to the right treatment earlier, faster and cheaper. Other projects are in different R&D and validation phases. They are all exclusive and disruptive for precision and personalized medicine.